Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products.

Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.
Managers
NameAgeSinceTitle
Arthur P. Bedrosian712000Chief Executive Officer & Director
Jeffrey Farber572003Chairman
Martin P. Galvan, CPA652011CFO, Treasurer & Vice President-Finance
Robert Ehlinger602006Chief Information Officer & VP-logistics
David A. Drabik492010Lead Independent Director
Paul Taveira572012Independent Director
James M. Maher642013Independent Director
Albert R. Paonessa III572015Independent Director
Kevin R. Smith572002Senior Vice President-Sales & Marketing
John Abt-2015Vice President-Quality
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 37,765,152 27,210,906 72.1% 604,866 1.6% 72.1%
Shareholders
NameEquities%
Telemus Capital LLC 6,482,126 17.4%
Jeffrey Farber 4,643,874 12.5%
David Farber 3,779,904 10.2%
BlackRock Fund Advisors 2,885,039 7.76%
The Vanguard Group, Inc. 2,490,659 6.70%
Snow Capital Management LP 2,117,912 5.70%
Deerfield Management Company LP 2,008,051 5.40%
Coatue Management LLC 1,580,790 4.25%
Invesco PowerShares Capital Management LLC 1,292,500 3.48%
SSgA Funds Management, Inc. 1,044,058 2.81%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.706
JOHNSON & JOHNSON-1.13%309 896
ROCHE HOLDING LTD.0.39%200 025
PFIZER INC.-3.14%190 910
NOVARTIS AG-4.32%183 809
MERCK & CO., INC.4.99%170 419
SANOFI-1.66%103 847
GLAXOSMITHKLINE PLC-0.99%93 604
BAYER AG3.40%89 744
ELI LILLY AND CO3.77%84 253
BRISTOL-MYERS SQUIBB C..-14.44%83 561
ALLERGAN PLC2.29%80 575
NOVO NORDISK A/S-2.32%70 912
ABBOTT LABORATORIES5.02%69 635
ASTRAZENECA PLC-2.68%66 624
SHIRE PLC-6.21%48 335
TAKEDA PHARMACEUTICAL ..-2.65%32 870
ASTELLAS PHARMA INC-5.87%29 124
MYLAN NV-5.56%19 280
EISAI CO., LTD-4.62%16 761
CHUGAI PHARMACEUTICAL ..-0.15%16 565
Sector Pharmaceuticals - NEC
Lannett Company, Inc. : Connections
Cranbrook & Co. Llc
Kremers Urban Pharmaceuticals, Inc.
Generic Pharmaceutical Co.
Auburn Pharmaceuticals, Inc.
Grason-Stadler, Inc.
National Response Corp.
The American Institute of Certified Public Accountants
Healthcare Distribution Management Association
Company contact information
Lannett Co., Inc.
13200 Townsend Road
Philadelphia, PA 19154

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
© 2017 People , Fundamentals and Ownership